3Saidi A, Alharethi R. Management of chemotherapy ind- uced cardiomyopathy[J]. Cur Cardiol Rev, 2011,7 (4): 245-249.
4Lipshultz SE, Rifai N, Dalton VM, et al. The effect of dexrazoxane on myocardial injury in doxorubiein--treat- ed children with acute lymphpblastie leukemia [J]. N Engl Med, 2004,35 l (2) : 145.
5Injac R,Strukelj B.Recent advances in protection against doxorubicin-induced toxicity[J].Technol Cancer Res Treat, 2008,7 (6):497 -516.
7Riley L C,Hann I M,Wheatley K. Treatment-related deaths during induction and first remission of acute myeloid leukaemia in children treated on the Tenth Medical Research Council acute myeloid leukaemia trial (MRC AML10).The MCR Childhood Leukaemia Working Party[J].British Journal of Haematology,1999,(02):436-444.
8Bowden G T,Roberts R,Albert D S. Comparative molecular Pharmacology in leukemia L 1210 cells of the anthracene anticancer drugs mitoxantrone and bisantrene[J].Cancer Research,1985.4915-4920.
9Liso V,Albano F,Pastore D. Bone marrow aspirate on the 14th day of induction treatment as a prognostic tool in de novo adult acute myeloid leukemia[J].Haematologica,2000,(12):1285-1290.
10Bienz M,Ludwig M,Leibundgut E O. Risk assessment in patients with acute myeloid leukemia and a normal ka ryotype[J].Clinical Cancer Research,2005,(04):1416-1424.
